Antibodies are referred as proteins produced by plasma cells of the
body which are used by immune system to identify and fight against
foreign bodies entering the host body. Antibodies are also known as
immunoglobulin (Ig). Antibodies are of Y shaped with specific binding
site for specific antigen, a foreign body that provokes an adaptive
immune response. Antibodies are secreted by type of white blood cells
(WBCs) namely, plasma cells.
Immunity strength is observed to be directly proportional to age.
With aging of population, the number of patients suffering diseases
caused by weak immunity is increasing. Thus, factors such as global
increase in the geriatric population, increasing research and
development activity in the immunology field and availability of the
government funds for research activities are driving the global
antibody technologies market towards growth. On the other hand, lack
of funds in developing economies, stringent regulatory framework and
poor adoption of new technologies are some of the factors restraining
the growth of the global antibody technologies market.
On the grounds of increased research and development activities
globally, immunofluorescence is the fastest growing segment among the
available research applications. Disease diagnosis segment is leading
the medical application segment due to advancements in research and
thereby entry of improved techniques in the market. Monoclonal
antibodies (mAb or moAb) is leading the segment and is followed by
Intravenous immunoglobulin (IVIg) in the antibody type based antibody
technology segment.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33962
Geographically, the global antibody technologies market is
categorized into North America, Europe, Asia-Pacific and rest of the
world regions. North America currently leads global antibody
technologies market and is followed by Europe. Factors that are
fueling the growth of antibody technology market in the North America
include existence of highly advanced technologies, early adoption of
new technologies, developed healthcare infrastructure and supportive
economy. Asia-Pacific is a lucrative market for antigen technologies
and is predicted to undergo fast market growth. Particularly,
countries such as India and China show growth potential, owing to
factors such as government support to develop biotechnology industry
in respective countries, rapidly improving healthcare infrastructure
and increased healthcare spending.
In addition, Asia Pacific countries mainly India and China will
attract patients on the grounds of rapidly developing medical tourism
industry in these countries and thereby resulting in increased demand
for antibody technologies market in this region. Some of the major
players contributing to the global antibody technologies market
include, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Biotest AG,
Shanghai RAAS Blood Products Co. Ltd., China Biologic Products, Inc.,
Bharat Serums and Vaccines Ltd., OMRIX Biopharmaceuticals Ltd.,
Kedrion S.p.A, Beijing Tiantan Biological Products Co. Ltd., Huanlan
Biological Engineering, Inc., Guizhou Taibang Biological Products Co.
Ltd., Grifols S.A., CSL Behring LLC, Baxter International, Inc. and
Octapharma AG.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=33962
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment